Literature DB >> 1667613

Effects of doxapram on ionic currents recorded in isolated type I cells of the neonatal rat carotid body.

C Peers1.   

Abstract

Whole-cell patch-clamp recordings were used to investigate the effects of the respiratory stimulant doxapram on K+ and Ca2+ currents in isolated type I cells of the neonatal rat carotid body. Doxapram (1-100 microM) caused rapid, reversible and dose-dependent inhibitions of K+ currents recorded in type I cells (IC50 approximately 13 microM). Inhibition was voltage-dependent, in that the effects of doxapram were maximal at test potentials where a shoulder in the current-voltage relationship was maximal. These K+ currents were composed of both Ca(2+)-activated and Ca(2+)-independent components. Using high [Mg2+], low [Ca2+] solutions to inhibit Ca(2+)-activated K+ currents, doxapram was also seen to directly inhibit Ca(2+)-independent K+ currents. This effect was voltage-independent and was less potent (IC50 approximately 20 microM) than under control conditions, suggesting that doxapram was a more potent inhibitor of the Ca(2+)-activated K+ currents recorded under control conditions. Doxapram (10 microM) was without effect on L-type Ca2+ channel currents recorded under conditions where K+ channel activity was minimized and was also without significant effect on K+ currents recorded in the neuronal cell line NG-108 15, suggesting a selective effect on carotid body type I cells. The effects of doxapram on type I cells show similarities to those of the physiological stimuli of the carotid body, suggesting that doxapram may share a similar mechanism of action in stimulating the intact organ.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1667613     DOI: 10.1016/0006-8993(91)91386-f

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

Review 1.  Acute oxygen-sensing mechanisms.

Authors:  E Kenneth Weir; José López-Barneo; Keith J Buckler; Stephen L Archer
Journal:  N Engl J Med       Date:  2005-11-10       Impact factor: 91.245

Review 2.  A new look at the respiratory stimulant doxapram.

Authors:  C Spencer Yost
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

Review 3.  A mitochondrial redox oxygen sensor in the pulmonary vasculature and ductus arteriosus.

Authors:  Kimberly J Dunham-Snary; Zhigang G Hong; Ping Y Xiong; Joseph C Del Paggio; Julia E Herr; Amer M Johri; Stephen L Archer
Journal:  Pflugers Arch       Date:  2015-09-23       Impact factor: 3.657

4.  A small molecule screening to detect potential therapeutic targets in human podocytes.

Authors:  Eugen Widmeier; Weizhen Tan; Merlin Airik; Friedhelm Hildebrandt
Journal:  Am J Physiol Renal Physiol       Date:  2016-10-19

Review 5.  Mechanisms of oxygen sensing: a key to therapy of pulmonary hypertension and patent ductus arteriosus.

Authors:  E K Weir; M Obreztchikova; A Vargese; J A Cabrera; D A Peterson; Z Hong
Journal:  Br J Pharmacol       Date:  2008-07-21       Impact factor: 8.739

6.  The bioavailability and maturing clearance of doxapram in preterm infants.

Authors:  Robert B Flint; Sinno H P Simons; Peter Andriessen; Kian D Liem; Pieter L J Degraeuwe; Irwin K M Reiss; Rob Ter Heine; Aline G J Engbers; Birgit C P Koch; Ronald de Groot; David M Burger; Catherijne A J Knibbe; Swantje Völler
Journal:  Pediatr Res       Date:  2020-07-22       Impact factor: 3.756

7.  Doxapram hydrochloride aggravates adrenaline-induced arrhythmias accompanied by bidirectional ventricular tachycardia.

Authors:  Shota Oikawa; Hiroko Nomura; Miki Nishio; Rina Nagata; Tadayoshi Hata
Journal:  ISRN Cardiol       Date:  2014-01-09

8.  A1899, PK-THPP, ML365, and Doxapram inhibit endogenous TASK channels and excite calcium signaling in carotid body type-1 cells.

Authors:  Peadar B O'Donohoe; Nicky Huskens; Philip J Turner; Jaideep J Pandit; Keith J Buckler
Journal:  Physiol Rep       Date:  2018-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.